Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · IEX Real-Time Price · USD
39.29
+0.30 (0.77%)
May 3, 2024, 4:00 PM EDT - Market closed
Structure Therapeutics Employees
Structure Therapeutics had 93 employees on December 31, 2023. The number of employees increased by 25 or 36.76% compared to the previous year.
Employees
93
Change (1Y)
25
Growth (1Y)
36.76%
Revenue / Employee
n/a
Profits / Employee
-$963,656
Market Cap
1.83B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 93 | 25 | 36.76% |
| Dec 31, 2022 | 68 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Owens & Minor | 22,200 |
| NeoGenomics | 2,100 |
| Ginkgo Bioworks Holdings | 1,218 |
| Twist Bioscience | 919 |
| Alphatec Holdings | 839 |
| Beam Therapeutics | 507 |
| Catalyst Pharmaceuticals | 167 |
| Edgewise Therapeutics | 88 |
GPCR News
- 17 days ago - Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates. - Market Watch
- 7 weeks ago - Wegovy and Zepbound Are King. Who's Coming for Their Crowns. - Barrons
- 2 months ago - Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference - GlobeNewsWire
- 2 months ago - Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights - GlobeNewsWire
- 3 months ago - The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space - CNBC
- 4 months ago - Five obesity-drug trends to watch in 2024: Who can compete with Eli Lilly and Novo Nordisk? - Market Watch
- 4 months ago - Structure Therapeutics reports promising results for weight-loss pill - Invezz
- 4 months ago - New Shakeup Hits Obesity Pills. Structure Rolls Out Disappointing Data. - Barrons